COLORECTAL ADENOCARCINOMA
Clinical trials for COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted liver pump shows promise for colorectal cancer metastases
Disease control CompletedThis study tested a treatment for colorectal cancer that has spread to the liver. A small pump placed under the skin delivers chemotherapy directly to the liver over two weeks. The goal was to see if this approach could shrink liver tumors. 24 adults took part, and the study is n…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:53 UTC
-
New hope for Hard-to-Treat gut cancers: first human trial launched
Disease control CompletedThis early study tested a new drug called Cabotamig (ARB202) in 33 adults with advanced gastrointestinal cancers (like stomach, liver, or bowel cancer) that had stopped responding to standard treatments. The drug works by targeting a marker called CDH17 on cancer cells and helpin…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Arbele Pty Ltd • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New combo therapy shows promise in shrinking liver tumors from colorectal cancer
Disease control CompletedThis early-phase study tested the safety of combining the immunotherapy drug pembrolizumab with precise radiation (SBRT) to the liver in 15 adults with colorectal cancer that had spread only to the liver. The goal was to see if this approach could prevent the cancer from returnin…
Matched conditions: COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated May 22, 2026 14:02 UTC